Delivery Order SPE2DB24D1205-SPE2DB25FCZYW
Award Date 8/27/25
Potential Completion Date 8/28/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,053.93 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Glycopyrrolate 0.2 mg/mL vials. This firm fixed-price, non-set-aside contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $367,720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.4 mg/2 ml vials of glycopyrrolate. The single award delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of the pharmaceutical to a facility in Conshohocken, Pennsylvania by July 31, 2023. As a major distributor of medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order to...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $6,379.02 delivery order to AmerisourceBergen Drug Corp for Glycopyrrolate Inject, with an ultimate completion date of June 26, 2024. This non-set-aside, firm fixed price contract was competitively awarded on June 25, 2024, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical transaction within the company's broader federal medical...
- This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,341.26, is for the supply of glycopyrrolate 0.2 mg/ml vials (20 ml) to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of May 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,108,712 units of the medication glycopyrrolate 0.2 mg/ml in 5 ml vials. The contract has a ceiling value of $4,674.96 and a period of performance through March 29, 2024. This delivery order contract was issued under a larger, single-award indefinite delivery contract (IDC) that Amerisourcebergen holds with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of GLYCOPYRROLATE 0.2 MG/ML VIAL 5ML, a pharmaceutical product, with a ceiling value of $14,134.70. The contract is a firm fixed-price arrangement with a completion date of May 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a $2,443.72 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of 2 ml vials of glycopyrrolate 0.2 mg/ml to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565616879 - GLYCOPYRROLATE 0.2 MG/ML VIAL 5ML. The contract has an ultimate completion date of August 29, 2024 and a ceiling value of $15,536.46. The contract is not set aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of glycopyrrolate 0.2 mg/ml vial, 2 ml, a medication used to treat certain medical conditions. The contract has a ceiling value of $4,591.37 and a completion date of July 22, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,685.05, is for the delivery of glycopyrrolate 1 mg/5 ml vials. This is a firm fixed-price delivery order contract with a completion date of June 12, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...